331 related articles for article (PubMed ID: 29398867)
1. Diet switch and omega-3 hydroxy-fatty acids display differential hepatoprotective effects in an obesity/nonalcoholic fatty liver disease model in mice.
Rodriguez-Echevarria R; Macias-Barragan J; Parra-Vargas M; Davila-Rodriguez JR; Amezcua-Galvez E; Armendariz-Borunda J
World J Gastroenterol; 2018 Jan; 24(4):461-474. PubMed ID: 29398867
[TBL] [Abstract][Full Text] [Related]
2. Improvement of insulin sensitivity after peroxisome proliferator-activated receptor-alpha agonist treatment is accompanied by paradoxical increase of circulating resistin levels.
Haluzik MM; Lacinova Z; Dolinkova M; Haluzikova D; Housa D; Horinek A; Vernerova Z; Kumstyrova T; Haluzik M
Endocrinology; 2006 Sep; 147(9):4517-24. PubMed ID: 16740970
[TBL] [Abstract][Full Text] [Related]
3. Anti-steatotic effects of an n-3 LCPUFA and extra virgin olive oil mixture in the liver of mice subjected to high-fat diet.
Valenzuela R; Espinosa A; Llanos P; Hernandez-Rodas MC; Barrera C; Vergara D; Romero N; Pérez F; Ruz M; Videla LA
Food Funct; 2016 Jan; 7(1):140-50. PubMed ID: 26471014
[TBL] [Abstract][Full Text] [Related]
4. Protective effects of various ratios of DHA/EPA supplementation on high-fat diet-induced liver damage in mice.
Shang T; Liu L; Zhou J; Zhang M; Hu Q; Fang M; Wu Y; Yao P; Gong Z
Lipids Health Dis; 2017 Mar; 16(1):65. PubMed ID: 28356106
[TBL] [Abstract][Full Text] [Related]
5. Differential effects of EPA, DPA and DHA on cardio-metabolic risk factors in high-fat diet fed mice.
Guo XF; Sinclair AJ; Kaur G; Li D
Prostaglandins Leukot Essent Fatty Acids; 2018 Sep; 136():47-55. PubMed ID: 29113747
[TBL] [Abstract][Full Text] [Related]
6. Effects of calycosin against high-fat diet-induced nonalcoholic fatty liver disease in mice.
Duan X; Meng Q; Wang C; Liu Z; Sun H; Huo X; Sun P; Ma X; Peng J; Liu K
J Gastroenterol Hepatol; 2018 Feb; 33(2):533-542. PubMed ID: 28699662
[TBL] [Abstract][Full Text] [Related]
7. Polychlorinated biphenyl 153 is a diet-dependent obesogen that worsens nonalcoholic fatty liver disease in male C57BL6/J mice.
Wahlang B; Falkner KC; Gregory B; Ansert D; Young D; Conklin DJ; Bhatnagar A; McClain CJ; Cave M
J Nutr Biochem; 2013 Sep; 24(9):1587-95. PubMed ID: 23618531
[TBL] [Abstract][Full Text] [Related]
8. Procyanidin B2 protects against diet-induced obesity and non-alcoholic fatty liver disease
Xing YW; Lei GT; Wu QH; Jiang Y; Huang MX
World J Gastroenterol; 2019 Feb; 25(8):955-966. PubMed ID: 30833801
[TBL] [Abstract][Full Text] [Related]
9. Paeoniflorin Protects against Nonalcoholic Fatty Liver Disease Induced by a High-Fat Diet in Mice.
Zhang L; Yang B; Yu B
Biol Pharm Bull; 2015; 38(7):1005-11. PubMed ID: 25972092
[TBL] [Abstract][Full Text] [Related]
10. [Liraglutide protects against nonalcoholic fatty liver disease in ApoE knockout mice with high-fat diet and silenced Acrp30 by increasing AMPK].
Zhao XY; Zhang LL; Suolang QZ; Yang GY; Li L; Li SB; Chen WW
Zhonghua Gan Zang Bing Za Zhi; 2014 Nov; 22(11):849-53. PubMed ID: 25531383
[TBL] [Abstract][Full Text] [Related]
11. Different Effects of Eicosapentaenoic and Docosahexaenoic Acids on Atherogenic High-Fat Diet-Induced Non-Alcoholic Fatty Liver Disease in Mice.
Suzuki-Kemuriyama N; Matsuzaka T; Kuba M; Ohno H; Han SI; Takeuchi Y; Isaka M; Kobayashi K; Iwasaki H; Yatoh S; Suzuki H; Miyajima K; Nakae D; Yahagi N; Nakagawa Y; Sone H; Yamada N; Shimano H
PLoS One; 2016; 11(6):e0157580. PubMed ID: 27333187
[TBL] [Abstract][Full Text] [Related]
12. Dietary DHA/EPA Ratio Changes Fatty Acid Composition and Attenuates Diet-Induced Accumulation of Lipid in the Liver of ApoE
Liu L; Hu Q; Wu H; Wang X; Gao C; Chen G; Yao P; Gong Z
Oxid Med Cell Longev; 2018; 2018():6256802. PubMed ID: 30538803
[TBL] [Abstract][Full Text] [Related]
13. Supplementation with Docosahexaenoic Acid and Extra Virgin Olive Oil Prevents Liver Steatosis Induced by a High-Fat Diet in Mice through PPAR-α and Nrf2 Upregulation with Concomitant SREBP-1c and NF-kB Downregulation.
Hernández-Rodas MC; Valenzuela R; Echeverría F; Rincón-Cervera MÁ; Espinosa A; Illesca P; Muñoz P; Corbari A; Romero N; Gonzalez-Mañan D; Videla LA
Mol Nutr Food Res; 2017 Dec; 61(12):. PubMed ID: 28940752
[TBL] [Abstract][Full Text] [Related]
14. Eicosapentaenoic and docosahexaenoic acid-enriched high fat diet delays the development of fatty liver in mice.
Soni NK; Nookaew I; Sandberg AS; Gabrielsson BG
Lipids Health Dis; 2015 Jul; 14():74. PubMed ID: 26193881
[TBL] [Abstract][Full Text] [Related]
15. Hydroxytyrosol prevents reduction in liver activity of Δ-5 and Δ-6 desaturases, oxidative stress, and depletion in long chain polyunsaturated fatty acid content in different tissues of high-fat diet fed mice.
Valenzuela R; Echeverria F; Ortiz M; Rincón-Cervera MÁ; Espinosa A; Hernandez-Rodas MC; Illesca P; Valenzuela A; Videla LA
Lipids Health Dis; 2017 Apr; 16(1):64. PubMed ID: 28395666
[TBL] [Abstract][Full Text] [Related]
16. Effects of eicosapentaenoic acid on hepatic dyslipidemia and oxidative stress in high fat diet-induced steatosis.
Hirotani Y; Ozaki N; Tsuji Y; Urashima Y; Myotoku M
Int J Food Sci Nutr; 2015; 66(5):569-73. PubMed ID: 26017323
[TBL] [Abstract][Full Text] [Related]
17. Singular effects of PPAR agonists on nonalcoholic fatty liver disease of diet-induced obese mice.
Barbosa-da-Silva S; Souza-Mello V; Magliano DC; Marinho Tde S; Aguila MB; Mandarim-de-Lacerda CA
Life Sci; 2015 Apr; 127():73-81. PubMed ID: 25748419
[TBL] [Abstract][Full Text] [Related]
18. Hydroxyeicosapentaenoic acids and epoxyeicosatetraenoic acids attenuate early occurrence of nonalcoholic fatty liver disease.
Wang C; Liu W; Yao L; Zhang X; Zhang X; Ye C; Jiang H; He J; Zhu Y; Ai D
Br J Pharmacol; 2017 Jul; 174(14):2358-2372. PubMed ID: 28471490
[TBL] [Abstract][Full Text] [Related]
19. Dietary saturated fatty acid and polyunsaturated fatty acid oppositely affect hepatic NOD-like receptor protein 3 inflammasome through regulating nuclear factor-kappa B activation.
Sui YH; Luo WJ; Xu QY; Hua J
World J Gastroenterol; 2016 Feb; 22(8):2533-44. PubMed ID: 26937141
[TBL] [Abstract][Full Text] [Related]
20. Adiponectin mediates the additive effects of combining daily exercise with caloric restriction for treatment of non-alcoholic fatty liver.
Cho J; Koh Y; Han J; Kim D; Kim T; Kang H
Int J Obes (Lond); 2016 Nov; 40(11):1760-1767. PubMed ID: 27216820
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
